This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (54)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Its Incidence and Course in 165 Patients Treated for Thyrotoxicosis with Iodine131

HENRY E. HAMILTON, M.D.; RICHARD O. SCHULTZ, M.D.; ELMER L. DE GOWIN, M.D.

AMA Arch Intern Med. 1960;105(5):675-685.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Exophthalmos is the ocular abnormality most often described in Graves' disease. Repeated emphasis on this aspect of the disease has diverted attention from other ocular disturbances. In fact, most synonyms emphasize this focus—Graves' disease with exophthalmos, exophthalmic goiter, malignant exophthalmos, endocrine exophthalmos, exophthalmic ophthalmoplegia, and exophthalmic ophthalmopathy. Inspection of the eyes in patients with thyroid disease, however, enables us to see a great variety of lesions causing many symptoms. Indeed, exophthalmos may not exist at all in an eye with grossly disturbed function. We have studied the elements of the eye disease associated with thyrotoxicosis and have described them under the term endocrine eye lesion. Hitherto the etiology, pathogenesis, and response to treatment have been studied in highly selected patients with severe eye lesions. In a comprehensive review of endocrine exophthalmos Wybar makes the point that "there is still no true understanding of the basic nature of the exophthalmic . . . [Full Text PDF of this Article]

Author Affiliations
Iowa City

From the Thyroid Clinic of the College of Medicine, State University of Iowa and University Hospital.; Professor of Internal Medicine (Dr. Hamilton); Research Fellow of the Department of Ophthalmology (Dr. Schultz); Professor of Internal Medicine (Dr. De Gowin).

Footnotes
Submitted for publication June 23, 1959.

These studies were aided by grants from the Iowa Division of The American Cancer Society and the Division of Biology and Medicine of the U.S. Atomic Energy Commission.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?